D. Addington, J. Addington, E. Maticka-tyndale, and J. Joyce, Reliability and validity of a depression rating scale for schizophrenics, Schizophr. Res, vol.6, pp.201-208, 1992.

C. Alvarado-esquivel, L. F. Sanchez-anguiano, J. Hernandez-tinoco, L. O. Berumen-segovia, Y. E. Torres-prieto et al., Toxoplasma gondii Infection and Mixed Anxiety and Depressive Disorder: A Case-Control Seroprevalence Study in Durango, Mexico. J. Clin. Med. Res, vol.8, pp.519-523, 2016.

M. Archer, O. Niemelä, M. Hämäläinen, E. Moilanen, E. Leinonen et al., The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients, Psychiatry Res, vol.264, pp.31-38, 2018.

G. D. Batty, K. J. Jung, S. Lee, J. H. Back, and S. H. Jee, Systemic inflammation and suicide risk: cohort study of 419 527 Korean men and women, J. Epidemiol. Community Health, vol.72, pp.572-574, 2018.

R. Bender and S. Lange, Adjusting for multiple testing-when and how?, J. Clin. Epidemiol, vol.54, pp.343-349, 2001.

M. Berk, L. J. Williams, F. N. Jacka, A. O'neil, J. A. Pasco et al., So depression is an inflammatory disease, but where does the inflammation come from, BMC Med, vol.11, 0200.

L. Brundin, S. Erhardt, E. Y. Bryleva, E. D. Achtyes, and T. T. Postolache, The role of inflammation in suicidal behaviour, Acta Psychiatr. Scand, vol.132, pp.192-203, 2015.

E. Bulzacka, L. Boyer, F. Schürhoff, O. Godin, F. Berna et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group, 2016. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset, Schizophr. Bull, vol.42, pp.1290-1302

R. Cáceda, W. S. Griffin, and P. L. Delgado, A probe in the connection between inflammation, cognition and suicide, J. Psychopharmacol. Oxf. Engl, vol.32, pp.482-488, 2018.

L. Capuron, J. Lasselin, and N. Castanon, Role of Adiposity-Driven Inflammation in Depressive Morbidity, Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol, vol.42, pp.115-128, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01602766

S. A. Everson-rose, T. T. Lewis, K. Karavolos, S. A. Dugan, D. Wesley et al., Depressive symptoms and increased visceral fat in middle-aged women, Psychosom. Med, vol.71, pp.410-416, 2009.

M. Faugere, J. Micoulaud-franchi, C. Faget-agius, C. Lançon, M. Cermolacce et al., High C-reactive protein levels are associated with depressive symptoms in schizophrenia, J. Affect. Disord, vol.225, pp.671-675, 2018.

G. Fond, W. Boukouaci, G. Chevalier, A. Regnault, G. Eberl et al., The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review, Pathol. Biol, vol.63, pp.35-42, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02157593

G. Fond, L. Boyer, F. Berna, O. Godin, E. Bulzacka et al., Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort, Br. J. Psychiatry J. Ment. Sci, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01814845

G. Fond, L. Boyer, F. Schürhoff, F. Berna, O. Godin et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, Schizophr. Res, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02473263

G. Fond, M. Albis, S. Jamain, R. Tamouza, C. Arango et al., The promise of biological markers for treatment response in firstepisode psychosis: a systematic review, Schizophr. Bull, vol.41, pp.559-573, 2015.

G. Fond, O. Godin, L. Brunel, B. Aouizerate, F. Berna et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2016. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set, J. Affect. Disord, vol.191, pp.209-215

G. Fond, N. Resseguier, F. Schürhoff, O. Godin, M. Andrianarisoa et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2017. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort, Eur. Arch. Psychiatry Clin. Neurosci

S. D. Gale, A. N. Berrett, B. Brown, L. D. Erickson, and D. W. Hedges, No association between current depression and latent toxoplasmosis in adults, Folia Parasitol. (Praha), vol.63, 2016.

J. Hannestad, N. Dellagioia, and M. Bloch, The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a metaanalysis, Neuropsychopharmacology, vol.36, pp.2452-2459, 2011.

S. Kharabian-masouleh, K. Arélin, A. Horstmann, L. Lampe, J. A. Kipping et al., Higher body mass index in older adults is associated with lower gray matter volume: implications for memory performance, Neurobiol. Aging, vol.40, pp.1-10, 2016.

S. Kharabian-masouleh, F. Beyer, L. Lampe, M. Loeffler, T. Luck et al., Gray matter structural networks are associated with cardiovascular risk factors in healthy older adults, J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab, vol.38, pp.360-372, 2018.

H. Klakk, P. L. Kristensen, L. B. Andersen, K. Froberg, N. C. Møller et al., Symptoms of depression in young adulthood is associated with unfavorable clinical-and behavioral cardiovascular disease risk factors, Prev. Med. Rep, vol.11, pp.209-215, 2018.

C. A. Köhler, T. H. Freitas, B. Stubbs, M. Maes, M. Solmi et al.,

N. Q. Andrade, G. Morris, B. S. Fernandes, A. R. Brunoni, N. Herrmann et al., Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis, Mol. Neurobiol, vol.55, pp.4195-4206, 2018.

C. Lançon, P. Auquier, G. Reine, D. Bernard, and M. Toumi, Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS), J. Affect. Disord, vol.58, pp.107-115, 2000.

S. H. Lee, G. Paz-filho, C. Mastronardi, J. Licinio, and M. Wong, Is increased antidepressant exposure a contributory factor to the obesity pandemic?, Transl. Psychiatry, vol.6, 2016.

N. Mackinnon, S. Zammit, G. Lewis, P. B. Jones, and G. M. Khandaker, Association between childhood infection, serum inflammatory markers and intelligence: findings from a population-based prospective birth cohort study, 2018.

, Epidemiol. Infect, vol.146, pp.256-264

Y. Milaneschi, F. Lamers, M. Bot, M. L. Drent, and B. W. Penninx, Leptin Dysregulation Is Specifically Associated With Major Depression With Atypical Features: Evidence for a Mechanism Connecting Obesity and Depression, Biol. Psychiatry, vol.81, pp.807-814, 2017.

R. A. Remigio-baker, M. A. Allison, P. J. Schreiner, M. Szklo, R. M. Crum et al., Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: the Multi-Ethnic Study of Atherosclerosis, Psychoneuroendocrinology, vol.47, pp.78-87, 2014.

F. Schürhoff, G. Fond, F. Berna, E. Bulzacka, J. Vilain et al., FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators, 2015. A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap, Eur. Psychiatry J. Assoc. Eur. Psychiatr

E. G. Severance, J. Xiao, L. Jones-brando, S. Sabunciyan, Y. Li et al., Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases, Int. Rev. Neurobiol, vol.131, pp.143-163, 2016.

A. L. Sutterland, G. Fond, A. Kuin, M. W. Koeter, R. Lutter et al., Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis, Acta Psychiatr. Scand, 2015.

J. Suvisaari, M. Torniainen-holm, M. Lindgren, T. Härkänen, and R. H. Yolken, Toxoplasma gondii infection and common mental disorders in the Finnish general population, J. Affect. Disord, vol.223, pp.20-25, 2017.

V. Valkanova, K. P. Ebmeier, and C. L. Allan, CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies, J. Affect. Disord, vol.150, pp.736-744, 2013.

R. Zhang, F. Beyer, L. Lampe, T. Luck, S. G. Riedel-heller et al., White matter microstructural variability mediates the relation between obesity and cognition in healthy adults, NeuroImage, vol.172, pp.239-249, 2018.

A. Zwicker, C. Fabbri, M. Rietschel, J. Hauser, O. Mors et al., Genetic disposition to inflammation and response to antidepressants in major depressive disorder, J. Psychiatr. Res, vol.105, pp.17-22, 2018.